Emerging Roles of Transforming Growth Factor β Signaling in Diabetic Retinopathy

Area of Science:

• Endocrinology
• Ophthalmology
• Molecular Biology

Background:

• Diabetic retinopathy (DR) affects one-third of diabetic adults, with limited late-stage treatment options.
• DR pathogenesis is linked to elevated glucose, insulin, and VEGF signaling.
• Emerging research highlights other factors, like transforming growth factor beta (TGF-β), in DR development.

Purpose of the Study:

• To review the intricate roles of TGF-β signaling in the pathogenesis and progression of diabetic retinopathy.
• To consolidate current understanding of TGF-β's contribution to DR.
• To identify TGF-β as a potential therapeutic target for DR.

Main Methods:

• Literature review of studies on TGF-β signaling in diabetic retinopathy.
• Analysis of established and emerging research on molecular pathways in DR.
• Synthesis of information regarding growth factors and their impact on DR.

Main Results:

• TGF-β signaling is recognized as a significant contributor to DR pathogenesis.
• The complex roles of TGF-β in DR progression are increasingly understood.
• TGF-β emerges as a potential therapeutic target for managing DR.

Conclusions:

• TGF-β signaling pathways are integral to the development and advancement of diabetic retinopathy.
• Further investigation into TGF-β's specific mechanisms in DR is warranted.
• Targeting TGF-β may offer novel therapeutic strategies for diabetic retinopathy.